Xiaoyao San ameliorates depressive-like behaviors and colonic inflammation in stress-colitis composite mice through the microbiota-gut-brain axis

Introduction Chronic psychological stress and intestinal inflammation may interact through the microbiota-gut-brain axis. Xiaoyao San (XYS), a classical traditional Chinese medicine formula, has long been used to alleviate gastrointestinal and emotional disorders, but the contribution of the gut microbiota to its effects remains unclear. Methods In this study, a chronic restraint stress combined with dextran sulfate sodium-induced stress-colitis composite mouse model was used to evaluate XYS with and without antibiotic-mediated microbiota depletion. Behavioral tests, histopathology, ELISA, immunofluorescence, Western blotting, LC-MS, molecular docking, and 16S rRNA sequencing were performed. Results XYS alleviated depressive-like behaviors, reduced serum corticosterone levels, attenuated colonic injury and inflammation, improved intestinal barrier-associated features, and ameliorated hippocampal inflammation and microglial activation. XYS also reduced NLRP3-related protein expression in both the colon and hippocampus and altered gut microbiota composition, with specific bacterial taxa associated with intestinal, behavioral, neuroendocrine, and neuroinflammatory indices. Notably, compared with the Antibiotic group, Antibiotic-XYS treatment further reduced colonic inflammatory cytokines and colonic NLRP3-related protein expression, indicating that part of the local anti-inflammatory effect of XYS was retained under antibiotic treatment. In contrast, the effects of XYS on intestinal barrier-associated features, depressive-like behaviors, serum corticosterone, hippocampal inflammation, microglial activation, and hippocampal NLRP3-related protein expression were markedly attenuated following antibiotic treatment. Discussion These differential responses indicate that improvement of local colonic inflammation alone is insufficient to account for the full intestinal and neurobehavioral effects of XYS. Overall, these findings support an important contribution of the gut microbiota to the intestinal and neurobehavioral actions of XYS along the microbiota-gut-brain axis.

Authors

Institutions

Publication Details

Journal
Frontiers in Microbiology
Published
2026-11-19
DOI
https://doi.org/10.3389/fmicb.2026.1955738
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Xiaoyao San ameliorates depressive-like behaviors and colonic inflammation in stress-colitis composite mice through the microbiota-gut-brain axis

Shengyuan Lin, Litao Yi, Yuxuan Huang, Yuan Cheng et al.
Frontiers in Microbiology
Gut microbiota and health
article

Xiaoyao San ameliorates depressive-like behaviors and colonic inflammation in stress-colitis composite mice through the microbiota-gut-brain axis

Shengyuan Lin, Litao Yi, Yuxuan Huang, Yuan Cheng, Zhiqiang Que, Weihong Yan, Xueqin Chen, Fangping Zheng
article en

Abstract

Introduction Chronic psychological stress and intestinal inflammation may interact through the microbiota-gut-brain axis. Xiaoyao San (XYS), a classical traditional Chinese medicine formula, has long been used to alleviate gastrointestinal and emotional disorders, but the contribution of the gut microbiota to its effects remains unclear. Methods In this study, a chronic restraint stress combined with dextran sulfate sodium-induced stress-colitis composite mouse model was used to evaluate XYS with and without antibiotic-mediated microbiota depletion. Behavioral tests, histopathology, ELISA, immunofluorescence, Western blotting, LC-MS, molecular docking, and 16S rRNA sequencing were performed. Results XYS alleviated depressive-like behaviors, reduced serum corticosterone levels, attenuated colonic injury and inflammation, improved intestinal barrier-associated features, and ameliorated hippocampal inflammation and microglial activation. XYS also reduced NLRP3-related protein expression in both the colon and hippocampus and altered gut microbiota composition, with specific bacterial taxa associated with intestinal, behavioral, neuroendocrine, and neuroinflammatory indices. Notably, compared with the Antibiotic group, Antibiotic-XYS treatment further reduced colonic inflammatory cytokines and colonic NLRP3-related protein expression, indicating that part of the local anti-inflammatory effect of XYS was retained under antibiotic treatment. In contrast, the effects of XYS on intestinal barrier-associated features, depressive-like behaviors, serum corticosterone, hippocampal inflammation, microglial activation, and hippocampal NLRP3-related protein expression were markedly attenuated following antibiotic treatment. Discussion These differential responses indicate that improvement of local colonic inflammation alone is insufficient to account for the full intestinal and neurobehavioral effects of XYS. Overall, these findings support an important contribution of the gut microbiota to the intestinal and neurobehavioral actions of XYS along the microbiota-gut-brain axis.

Frontiers in MicrobiologyVol. 17
Fujian University of Traditional Chinese Medicine (CN), Huaqiao University (CN), Xiamen University (CN), First Affiliated Hospital of Xiamen University (CN), First Affiliated Hospital of Fujian Medical University (CN)
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon